Stratec SE (STSEY) Research
Stratec SE, an international company with various subsidiaries, focuses on developing and manufacturing automated instruments and sophisticated solutions for the in-vitro diagnostics and life sciences industries. Its commercial reach extends across Germany, the broader European Union, and other global regions. The company's operations are divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation division designs and produces advanced automated analyzer systems, including necessary replacement parts and supplies, serving customers in clinical diagnostics and biotechnology. The Diatron segment delivers a suite of systems, individual components, consumables, and diagnostic tests, particularly for low-throughput applications in hematology and clinical chemistry. Furthermore, the Smart Consumables division is dedicated to creating and manufacturing innovative consumables tailored for diagnostics, life sciences, and medical technology applications. Originally known as STRATEC Biomedical AG, the company rebranded to Stratec SE in December 2018. Founded in 1979, its main corporate office is situated in Birkenfeld, Germany.
Market snapshot
- Symbol
- STSEY
- Price
- $5.51
- Day change
- 0.00%
- Market cap
- $221.0M
- P/E ratio
- -67.87x
- 52-week range
- 5-6.7
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
Peer companies
Open Stratec SE (STSEY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.